Interleukin‐23 inhibitors demonstrate high effectiveness in the treatment of a real‐world cohort of 82 psoriatic patients regardless of the HLA‐Cw6 status.
- Resource Type
- Article
- Source
Dermatologic Therapy . Oct2022, Vol. 35 Issue 10, p1-3. 3p.- Subject
- *
INTERLEUKIN-23
*TREATMENT effectiveness
*PSORIATIC arthritis - Language
- ISSN
- 1396-0296